Table 2.
7 through 10 days after vaccination (risk interval) |
15 through 42 days after vaccination (control interval) |
||||||
---|---|---|---|---|---|---|---|
Gestational age category | Number of children | Number of seizures | Incidence ratea (95% CI) | Number of seizures | Incidence ratea (95% CI) | IRR (95% CI)b | Preterm vs full-term, ratio of IRR (95% CI), p |
Overall | |||||||
Preterm (<37 weeks) | 45,343 | 31 | 62 (42–89) | 56 | 16 (12–21) | 3.9 (2.5–6.0) | 1.2 (0.76–1.9), 0.41 |
<35 weeks | 16,586 | 10 | 55 (26–100) | 22 | 17 (11–26) | 3.2 (1.5–6.7) | 1.0 (0.47–2.1), 0.99 |
35–36 weeks | 28,757 | 21 | 67 (41–100) | 34 | 15 (11–22) | 4.3 (2.5–7.4) | 1.4 (0.77–2.4), 0.29 |
Full-term (≥37 weeks) | 487,032 | 232 | 43 (38–49) | 510 | 14 (12–15) | 3.2 (2.7–3.7) | |
Vaccine received | |||||||
MMR | |||||||
Preterm | 37,262 | 22 | 54 (34–82) | 48 | 17 (12–22) | 3.2 (1.9–5.3) | 1.2 (0.70–2.0), 0.51 |
Full-term | 403,238 | 163 | 37 (31–43) | 425 | 14 (12–15) | 2.7 (2.2–3.2) | |
MMRV | |||||||
Preterm | 8081 | 9 | 100 (47–190) | 8 | 13 (5.6–25) | 7.9 (3.0–20) | 1.4 (0.51–3.8), 0.52 |
Full-term | 83,794 | 69 | 76 (59–95) | 85 | 13 (11–16) | 5.7 (4.1–7.8) | |
Child’s age at vaccination | |||||||
12–15 months | |||||||
Preterm | 41,391 | 27 | 60 (39–87) | 51 | 16 (12–21) | 3.7 (2.3–5.9) | 1.3 (0.77–2.1), 0.36 |
Full-term | 442,919 | 200 | 41 (36–47) | 477 | 14 (13–15) | 2.9 (2.5–3.5) | |
16–23 months | |||||||
Preterm | 3952 | 4 | 92 (25–237) | 5 | 17 (5.4–39) | 5.6 (1.5–21) | 0.82 (0.20–3.4), 0.79 |
Full-term | 44,113 | 32 | 66 (45–94) | 33 | 10 (6.7–14) | 6.8 (4.2–11) |
Abbreviations: MMR, measles-mumps-rubella; MMRV, measles-mumps-rubella-varicella; IRR: incident rate ratio, CI, confidence interval.
Per 1000 person-years.
IRR (7–10 days versus 15–42 days after vaccination).